Back to top Open menu arrow
Download PDF Reprints

The Journal of
Clinical Psychiatry
Free access

Correction March 25, 2026

Correction. The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia

J Clin Psychiatry 2026;87(2):26lcx16443

In the article “The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia” by Roger S. McIntyre, MD; Desiree M. Matthews, PMHNP-BC; Christina Arevalo, MS; David McDonnell, MD; and Christoph U. Correll, MD, published online March 9, 2026 (J Clin Psychiatry 2026;87[2]:25m16170), data shown in the “Predominant negative symptoms” column of Table 2 have been corrected to align with the Marder Negative Factor rows.

Published Online: March 25, 2026. 
DOI: 10.4088/JCP.26lcx16443
J Clin Psychiatry 2026;87(2):26lcx16443

 

This PDF is free for all visitors!

Cover features March 2026 issue highlighting articles on psychiatric drugs, peer interventions for perinatal depression, and metformin.

Vol 87 • 2026 • Number 1

Read the Current Issue

Original Research

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Meta-Analysis

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Original Research

Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients

Editorial

Thank You to the JCP Community

Editorial

Psychotherapy: Integral to Clinical Psychiatry

Original Research

Trends in Benzodiazepine Prescribing to Adults in the United States
View current Issue

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe